Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Inspire Medical Systems, Inc.    INSP

INSPIRE MEDICAL SYSTEMS, INC.

(INSP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e) 2020 (e) 2021 (e)
Sales 50,6 78,9 108 140
EBITDA -20,0 -32,6 -33,4 -33,2
Operating profit (EBIT) -20,4 -35,9 -38,4 -35,8
Pre-Tax Profit (EBT) -21,8 -34,3 -41,4 -36,0
Net income -21,8 -34,0 -38,6 -36,0
P/E ratio -28,2x -55,1x -49,3x -52,5x
EPS ( $ ) -1,50 -1,43 -1,59 -1,50
Dividend per Share ( $ ) - - - -
Yield - - - -
Reference price ( $ ) 42,250 78,560 78,560 78,560
Announcement Date 02/26/2019
09:15pm
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e) 2020 (e) 2021 (e)
Debt - - - -
Finance 163 0,00 0,00 137
Operating income (EBITDA) -20,0 -32,6 -33,4 -33,2
Leverage
(Debt/EBITDA)
- - - -
Capital Expenditure 0,25 3,00 1,00 1,00
Free Cash Flow (FCF) -18,9 -39,0 -41,0 -29,0
Book Value Per Share (BVPS) (  ) - 5,76 4,16 2,87
Cash Flow per Share ( $ ) -1,28 2,15 1,53 2,20
Announcement Date 02/26/2019
09:15pm
- - -
Balance Sheet Analysis
Assessed data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 1 838 M $ -
Valuation 2019e 2020e
P/E ratio (Price / EPS) -55,1x -49,3x
Capitalization / Revenue 23,3x 17,0x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 13,6x 18,9x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) -45,5% -35,7%
Operating Leverage (Delta EBIT / Delta Sales) - -
Net Margin (Net Profit / Revenue) -43,1% -35,8%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) -21,8% -
Rate of Dividend - -
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   3,80% 0,93%
Cash Flow / Sales 63,9% 33,1%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend